Results 121 to 130 of about 6,753 (182)

The efficacy of high-dose cabergoline treatment of prolactinomas resistant to standard doses: a clinical observation

open access: diamond, 2019
З. А. Калмыкова   +5 more
openalex   +2 more sources

Real-life data on pasireotide in monotherapy or combined in active Cushing's disease. [PDF]

open access: yesFront Endocrinol (Lausanne)
Mondin A   +6 more
europepmc   +1 more source

The use of the dopamine agonist cabergoline in the therapy of surgically induced endometriosis in rats

open access: diamond, 2018
Maria I. Yarmolinskaya   +3 more
openalex   +1 more source

Long-term primary pharmacotherapy of giant prolactinomas: A comparison of different cabergoline dosages. [PDF]

open access: yesJ Clin Transl Endocrinol
Václav H   +11 more
europepmc   +1 more source

"Cabergoline, Levosimendan and Iabp: Treatment of Peripartum Cardiomyopathy"

open access: diamond, 2016
Silvia Donfrancesco   +50 more
openalex   +1 more source

Somatostatin 5 receptor expression in prolactinomas: Is there a role for Pasireotide in the management of prolactinomas? [PDF]

open access: yesPituitary
Agrawal N   +11 more
europepmc   +1 more source

Effect of cabergoline on the management of diabetes mellitus: a systematic review and meta-analysis. [PDF]

open access: yesCardiovasc Diabetol Endocrinol Rep
Khorasani S   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy